Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Am Soc Nephrol ; 21(5): 868-75, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20203160

RESUMO

Prolonged CD4 T cell lymphopenia after administration of polyclonal anti-thymocyte globulins increases the rate of posttransplantation morbidity, but whether impaired immune reconstitution affects survival is unknown. We studied the effect of CD4 T cell lymphopenia on survival in 302 consecutive prevalent renal transplant recipients and the role of thymic function in CD4 T cell reconstitution and posttransplantation outcomes in 100 consecutive incident renal transplant recipients. We followed the prevalent cohort for a mean duration of 92 months. Of these 302 patients, 81 (27%) had persistent CD4 T cell counts <300/mm3 and 36 (12%) died during follow-up. We observed a higher death rate in patients with CD4 T cell lymphopenia persisting for >1 year (24.1 versus 7.6%; P < 0.001). Furthermore, in Cox regression analysis, CD4 T cell lymphopenia associated with a nearly five-fold risk for death (adjusted hazard ratio [HR] 4.63; 95% confidence interval [CI] 1.91 to 10.65; P = 0.001). In the incident cohort, we estimated thymic function by T cell receptor excision circles (TRECs) per 150,000 CD3+ cells, which predicted efficient CD4 T cell reconstitution. Higher pretransplantation TREC values associated with lower risks for cancer (adjusted HR 0.39; 95% CI 0.15 to 0.97; P = 0.046) and infection (HR 0.29; 95% CI 0.11 to 0.78; P = 0.013). In summary, prolonged polyclonal anti-thymocyte globulin-induced CD4 T cell lymphopenia is an independent risk factor for death. Determination of pretransplantation thymic function may identify patients at higher risk for CD4 T cell lymphopenia and posttransplantation morbidity, including cancer and infections.


Assuntos
Soro Antilinfocitário/efeitos adversos , Imunossupressores/efeitos adversos , Transplante de Rim , Complicações Pós-Operatórias/mortalidade , T-Linfocitopenia Idiopática CD4-Positiva/mortalidade , Adulto , Feminino , França/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/induzido quimicamente , Estudos Prospectivos , Subpopulações de Linfócitos T , T-Linfocitopenia Idiopática CD4-Positiva/induzido quimicamente , Timo/efeitos dos fármacos , Timo/imunologia
2.
Joint Bone Spine ; 76(2): 202-4, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19147387

RESUMO

Parsonage-Turner syndrome, also known as acute brachial neuritis or neuralgic amyotrophy, can be caused by various infectious agents. We report on four patients who experienced Parsonage-Turner syndrome as the first manifestation of Lyme disease. The clinical picture was typical, with acute shoulder pain followed rapidly by weakness and wasting of the shoulder girdle muscles. Electrophysiological testing showed denervation. A single patient reported erythema chronicum migrans after a tick bite. Examination of the cerebrospinal fluid showed lymphocytosis and protein elevation in 3 patients. Serological tests for Lyme disease were positive in the serum in all 4 patients and in the cerebrospinal fluid in 2 patients. Antibiotic therapy ensured a favorable outcome in all 4 cases. Two patients achieved a full recovery within 6 months. Parsonage-Turner syndrome should be added to the list of manifestations of neuroborreliosis. Serological tests for Lyme disease should be performed routinely in patients with Parsonage-Turner syndrome.


Assuntos
Neurite do Plexo Braquial/diagnóstico , Doença de Lyme/diagnóstico , Dor de Ombro/diagnóstico , Adulto , Idoso , Antibacterianos/uso terapêutico , Borrelia burgdorferi/imunologia , Borrelia burgdorferi/isolamento & purificação , Neurite do Plexo Braquial/tratamento farmacológico , Neurite do Plexo Braquial/microbiologia , Diagnóstico Diferencial , Feminino , Humanos , Doença de Lyme/complicações , Doença de Lyme/tratamento farmacológico , Linfocitose/líquido cefalorraquidiano , Linfocitose/microbiologia , Masculino , Pessoa de Meia-Idade , Dor de Ombro/tratamento farmacológico , Dor de Ombro/microbiologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...